Skip to main content
Log in

R-(+)-verapamil, S-(-)-verapamil, and racemic verapamil inhibit human retinal pigment epithelial cell contraction

  • Laboratory Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract 

Purpose: To evaluate the effects of R-(+)-verapamil, S-(-)-verapamil, and the racemate on in vitro contraction of human retinal pigment epithelial cells.Methods: RPE cells from human donor eyes were enzymatically dissociated and cultured on collagen gels. Transdifferentiated RPE cells (seventh and eighth passage) were used for experiments. The contraction assays were treated with different concentrations (10−1000 µM) of R-(+)-verapamil, S-(-)-verapamil, and racemic verapamil. Results: Verapamil inhibited the gel contraction of human RPE cells. R-(+)-verapamil, S-(-)-verapamil, and racemic verapamil acted equally in a dose-dependent manner from 10–1000 µM.Conclusion: The results indicate the effectiveness of verapamil to inhibit the contraction of RPE cells. R-(+)-verapamil is recom-

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 25 August 1999 Revised: 3 November 1999 Accepted: 4 November 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faude, F., Enzmann, V., Pöschmann, E. et al. R-(+)-verapamil, S-(-)-verapamil, and racemic verapamil inhibit human retinal pigment epithelial cell contraction. Graefe's Arch Clin Exp Ophthalmol 238, 537–541 (2000). https://doi.org/10.1007/PL00007897

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007897

Keywords

Navigation